CBAM is no longer just a reporting requirement; it is a measurable cost for every imported good
Learn why pharma companies should rely on biomethane as a scalable, credible, and readily available low-carbon solution to address their scope 1 footprint.
Learn how 3Degrees helped a client understand the RNG (biomethane) landscape to reduce its scope 1 emissions.
Explore the proposed changes to the Greenhouse Gas Protocol's Scope 2 Guidance and potential impacts to your renewable energy strategy.
Catch up on the valuable content covered in our North America and European PPA options Masterclass.
We examine the challenges companies face in meeting near-term supply chain emissions targets amid lagging updates to major climate standards, explore best practices for applying market-based accounting approaches to supply chain decarbonization, and introduce our Supply Chain Emissions Reduction solution.
